期刊文献+

Values of high-resolution computed tomography and pulmonary function tests in managements of patients with chronic hepatitis C virus infection 被引量:1

Values of high-resolution computed tomography and pulmonary function tests in managements of patients with chronic hepatitis C virus infection
下载PDF
导出
摘要 AIM:To investigate pulmonary involvement via pulmonary function tests (PFT) and high-resolution computed tomography (HRCT) in patients with chronic hepatitis C virus (HCV) infection.METHODS:Thirty-four patients with chronic HCV infection without diagnosis of any pulmonary diseases and 10 healthy cases were enrolled in the study. PFT and HRCT were performed in all cases.RESULTS:A decrease lower than 80% of the predicted value was detected in vital capacity in 9/34 patients, in forced expiratory volume in one second in 8/34 palJents, and in forced expiratory flow 25-75 in 15/34 patients, respectively. Carbon monoxide diffusing capacity (DLCO) was decreased in 26/34 patients. Findings of interstitial pulmonary involvement were detected in bhe HRCT of 16/34 patients. Significant difference was found between controls and patients with HCV infection in findings of HRCT (X^2=4.7, P=0.003). Knodell histological activity index (KHAI) of 28/34 patients in whom liver biopsy was applied was 9.0±4.7. HRCT findings, PFT values and DLCO were not affected by KHAI in patients with HCV infection. In these patients, all the parameters were related with age.CONCLUSION: We suggest that chronic hepatitis C virus infection may cause pulmonary interstitial involvement without evident respiratory symptoms. AIM:To investigate pulmonary involvement via pulmonary function tests (PFT) and high-resolution computed tomocjraphy (HRCT) in patients with chronic hepatitis C virus (HCV) infection. METHODS:Thirty-four patients with chronic HCV infection without diagnosis of any pulmonary diseases and 10 healthy cases were enrolled in the study,PFT and HRCT were performed in all cases. RESULTS:A decrease lower than 80% of the predicted value was detected in vital capacity in 9/34 patients,in forced expiratory volume in one second in 8/34 patients,and in forced expiratory flow 25-75 in 15/34 patients,respectively.Carbon monoxide diffusing capacity (DLCO) was decreased in 26/34 patients.Findings of interstitial pulmonary involvement were detected in the HRCT of 16/34 patients.Significant difference was found between controls and patients with HCV infection in findings of HRCT (X^2=4.7,P=0.003).Knodell histological activity index (KHAI) of 28/34 patients in whom liver biopsy was applied was 9.0±4.7.HRCT findings,PFT values and DLCO were not affected by KHAI in patients with HCV infection.In these patients,all the parameters were related with age. CONCLUSION:We suggest that chronic hepatitis C virus infection may cause pulmonary interstitial involvement without evident respiratory symptoms.
出处 《World Journal of Gastroenterology》 SCIE CAS CSCD 2004年第3期381-384,共4页 世界胃肠病学杂志(英文版)
关键词 慢性丙型肝炎 高分辨CT 肺功能 影像学诊断 纤维化 呼吸功能 Respiratory Function Tests Tomography, X-Ray Computed Adult Aged Female Hepatitis C, Chronic Humans Lung Diseases Male Middle Aged
  • 相关文献

参考文献21

  • 1Alter MJ. Epidemiology of hepatitis C in the west. Semin Liver Dis 1995; 15:5-14.
  • 2Hoofnagle JH. Hepatitis C: The clinical spectrum of disease.Hepatology 1997; 26(Suppl 1): 15S-20S.
  • 3Ferri C, Monti M, La Civita L, Longombardo G, Greco F, Pasero G, Gentilini P, Bombardieri S, Zignego AL. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobunemia. Blood 1993; 82:3701-3704.
  • 4Pawlotsky JM, Roudot-Thoraval F, Simmonds P, Mellor J, Ben Yahia MB, Andre C, Voisin MC, Intrator L, Zafrani ES, Duval J,Dhumeaux D. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995; 122:169-173.
  • 5Ferri C, La Civita L, Fazzi P, Solfanelli S, Lombardini F,Begliomini E, Monti M, Longombardo G, Pasero G, Zignego AL.Interstitial lung fibrosis and rheumatic disorders in patients with hepatitis C virus infection. Br J Rheumatol 1997; 36:360-365.
  • 6Weidensaul D, Imam T, Holyst MM, King PD, McMurray RW.Polymyositis, pulmonary fibrosis and hepatitis C virus. Arthritis Rheum 1995; 38:437-439.
  • 7Hubbard R, Lewis S, Richards K, Johnston I, Britton J. Occupational exposure to metal or wood dust and aefiology of cryptogenic fibrosing alveolitis. Lancet 1996; 347:284-289.
  • 8Scott j, Johnston I, Britton J. What causes cryptogenic fibrosing alveolitis? A case-control study of environmental exposure to dust. BMJ 1990; 301:1015-1017.
  • 9Ueda T, Ohta K, Suzuki N, Yamaguchi M, Hirai K, Horiuchi T,Watanabe J, Miyamoto T, Ito K. Idiopathic pulmonary fibrosis and high prevalence of serum antibodies to hepatitis C virus.Am Rev Respir Dis 1992; 146:266-268.
  • 10Vergnon JM, Vincent M, De The G, Momex JF, Weynants P, Brune J. Cryptogenic fibrosing alveolitis and Epstain-Barr Virus: An association? Lancet 1984; 2:768-771.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部